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1 |  INTRODUCTION
It is generally accepted that a given cause induces an effect 
except in cases where the responsiveness of a system changes. 
Pavlov is believed to have provided the main historical 
milestone that challenged the cause–effect relationship when 
discovering associative memory. Pavlov showed that salivary 
secretion could be produced by a previously inactive stimulus 
(the sound of a ring), which implies that systems can respond 
differently. Pavlov's disciples (Planelles and Luwisch) sought 
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Abstract
This study associates cholinergic stimulation of the pancreatic β-cell electrical ac-
tivity with a short-term memory phenomenon. Glucose pulses applied to a basal 
glucose concentration induce depolarizing waves which are used to estimate the evo-
lution of the β-cell glucose sensitivity. Exposure to carbamoylcholine (carbachol) 
increases the size of the glucose-induced depolarizing waves. This change appears 
after carbachol withdrawal and implies a temporal potentiation of sensitivity (TPS) 
lasting up to one hour. TPS induction requires the simultaneous action of carbachol 
and glucose. The substitution of glucose with the secretagogues glyceraldehyde or 
2-ketoisocaproate mimics glucose-induced TPS, while palmitate does not. TPS is not 
produced if the membrane is kept hyperpolarized by diazoxide. Glucose can be re-
placed by tolbutamide, suggesting a role of depolarization and a subsequent increase 
in intracellular calcium concentration. A role for kinases is suggested because stau-
rosporine prevents TPS induction. Cycloheximide does not impair TPS induction, 
indicating that de novo protein synthesis is not required. The fact that the two inputs 
acting simultaneously produce an effect that lasts up to one hour without requiring de 
novo protein synthesis suggests that TPS constitutes a case of short-term associative 
conditioning in non-neural tissue. The convergence of basal glucose levels and mus-
carinic activation happens physiologically during the cephalic phase of digestion, in 
order to later absorb incoming fuels. Our data reveals that the role of the cephalic 
phase may be extended, increasing nutrient sensitivity during meals while remaining 
low between them.
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parallel effects in other equally innervated systems (Planelles 
& Luwisch, 1935,1936). They suggested conditioned hy-
poglycemia as a parallel to classical Pavlovian experiments 
applied to the endocrine pancreas. The turbulence of the 
Spanish Civil War overshadowed the publication of this first 
description, thus it is frequently attributed to Mityushov 
(1954) (as cited by Overduin, Dworkin, & Jansen, 1997), 
who also demonstrated conditioned hypoglycemia following 
procedures that closely resembled Pavlov's. Likewise, clas-
sical conditioning experiments have shown that secretion of 
insulin can be controlled by stimuli in rats, dogs, and humans 
(Woods, Alexander, & Porte, 1972). Woods et al described 
conditioned hypoglycemia by inducing insulin secretion in 
rats in response to an olfactory stimulus (Woods, 1983).
Conditioned hypoglycemia is due to the secretion of insulin 
activated by the cholinergic fibers of the vagus nerve (Porte, 
Girardier, Seydoux, Kanazawa, & Posternak, 1973; Woods, 
1972). Atropine or severing the vagi eliminates conditioning 
(Bergman & Miller, 1973; Woods, Hutton, & Makous, 1970). 
On the other hand, Cerasi (1981), Nesher and Cerasi (1987), 
Nesher, Eylon, Segal, and Cerasi (1989) demonstrated that 
the effect of β-cell secretagogues is not limited solely to acute 
stimulation, coining the expressions time-dependent inhibition 
(TDI) and time-dependent potentiation (TDP) to describe the 
desensitization and sensitization that result in reduced or am-
plified insulin. These authors also found that these changes 
remained after withdrawing the agent. TDP has been well-char-
acterized (Nesher, Praiss, & Cerasi, 1988) and confirmed 
(Rasmussen et al., 1995). One case of TDP is called proemial 
sensitization, in which priming of insulin secretion was induced 
by acetylcholine applied at glucose concentrations incapable of 
producing TDP (Rasmussen et al., 1995; Zawalich, Zawalich, 
& Rasmussen, 1989). Thus, the existence of some memory in 
the islets of Langerhans (Zawalich, Diaz, & Zawalich, 1988; 
Zawalich & Zawalich, 1988), maybe responsible for the varying 
responsiveness that depends on the previous history of secret-
agogue exposure. Furthermore, this mechanism has been related 
to the pathophysiology of obesity (see ref. 18 for a review). The 
vagal ability to modulate insulin secretion has been confirmed 
(Gilon & Henquin, 2001), and there is consensus in considering 
vagal innervation as the part of the nervous system that stimu-
lates ‘rest and digest’ and ‘feed and breed’ processes(Trajkovski 
& Wollheim, 2016) and is considered to be involved in the de-
velopment of diet-induced obesity (Lartigue, 2016).
While these advances concerning pancreatic respon-
siveness were made throughout the twentieth century, other 
notable advances contributed to our understanding of the 
vagal molecular effect. The pancreatic cholinergic innerva-
tion is part of the vagal branching (Woods & Porte, 1974). 
Cholinergic agents were first reported in 1967 to stimulate 
insulin release from pieces of rat pancreas incubated in 
the presence of a low concentration of glucose (5.6  mM). 
Thus, in the presence of glucose either acetylcholine or 
carbamoylcholine (carbachol) increased insulin output 
(Malaisse, Malaisse Lagae, Wright, & Ashmore, 1967). In 
this aforementioned study, atropine eliminated the insulin 
secretory response to the cholinergic agents, while not af-
fecting that of glucose. Stimulation of insulin secretion by 
the cholinergic pathway involves a sophisticated sequence 
of cellular events, starting with the occupation of musca-
rinic receptors, followed by the activation of phospholipase 
C and the liberation of diacylglycerol and inositol 1,4,5-tri-
phosphate from membrane phosphoinositides, the activation 
of protein kinase C by diacylglycerol, and the mobilization 
of intracellular calcium ions by inositol 1,4,5-triphosphate. 
These biochemical events lead to a remodeling of ionic 
fluxes and induction of bioelectrical activity (Malaisse, 
1986). Later, it was reported that the administration of 
acetylcholine to the islets exposed to glucose changed in a 
rapid, sustained, and rapidly reversible manner, the bioelec-
tric bursting pattern into one of continuous activity, the re-
sponse to the cholinergic agent being opposed by atropine 
(Gagerman, Idahl, Meissner, & Täljedal, 1978). Likewise, in 
1988, cholinergic agonist carbachol was found to stimulate 
the release of insulin, and cause, in the pancreatic β-cells, an 
initial rapid depolarization with an increased rate of firing. 
Atropine suppresses the effects of carbachol on electrical ac-
tivity (Sanchez-Andres, Ripoll, & Soria, 1988).
Although the original descriptions of modifiability in the 
physiology of the endocrine pancreas are about 100 years old, 
three areas require further study: a. the existence of electro-
physiological counterparts to these phenomena, b. the extent 
to which memory in the islets of Langerhans is an observable 
property at the cellular level (β-cells), and c. the electrophys-
iological characterization at the cellular level of this effect. 
This research aims to provide insight into these unresolved 
questions and demonstrate that pancreatic β-cells are a po-
tential model of non-neural associative conditioning. In this 
paper, we show that the application of carbachol (mimicking 
a vagal discharge) to isolated islets of Langerhans can modify 
their response to glucose. We suggest that pancreatic β-cells 
are endowed with a modality of associative conditioning 
(Bliss & Collingridge, 1993), which shows some degree of 
parallelism with others described in neural systems (Bliss & 
Collingridge, 1993; Bliss & Lomo, 1973). This mechanism 
can play an essential physiological role, increasing the sensi-
tivity of β-cells during meals.
2 |  MATERIAL AND METHODS
2.1 | Study approval
The experiments were carried out according to institu-
tional animal care guidelines. Animal housing and all pro-
tocols were approved and in accordance with institutional 
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guidelines, Spanish animal protection laws, and conformed 
to the Directive 2010/63 EU of the European Parliament. The 
experimental protocol was approved by the Ethics Committee 
for Research and Animal Welfare of the University Jaume 
I (License reference: 2015/VSC/PEA/00053). Mice were 
housed in standard conditions.
2.2 | Experimental animals and islet 
preparation
OF-1 albino, 2–4-month-old mice were used. The animals 
were killed by cervical dislocation. The islets of Langerhans 
were obtained as previously described (Andreu, Soria, 
& Sanchez-Andres, 1997; Sanchez-Andres, Malaisse, & 
Kojima, 2019). A complete laparotomy was done to extract 
the pancreas and then attach it to the bottom of a Petri dish. 
The islets were microdissected by hand with the help of a 
stereomicroscope. The Petri dish was filled with a modified 
Krebs solution with the following composition (in mM): 120 
NaCl, 25 NaHCO3, 5 KCl, 2.6 CaCl2 and 1 MgCl2, and was 
equilibrated with a gas mixture containing 95% O2 and 5% 
CO2 at RT. In these conditions, viable islets could be ob-
tained for more than 8 hr. The islets were transferred to the 
recording chamber after the microdissection.
2.3 | Electrophysiological recording
The intracellular electrical activity (membrane potential) of 
β-cells was recorded from the microdissected islets continu-
ously perifused with the modified Krebs solution at 36ºC (pH 
7.4). The volume of the chamber was 50 μl and the flow 1 ml/
min, allowed for a fast washout of the applied drugs.
Borosilicate sharp microelectrodes (OD, 2.0  mM; 
ID. 1.0  mm, Sutter Instruments, Co.) were pulled with a 
Narishige PE2 puller (Narishige, Japan). The electrodes 
were filled with 3 M potassium citrate and 50 mM KCl. An 
Axoprobe microelectrode amplifier (Axon Instruments) was 
used to perform electrophysiological recordings. Data were 
acquired at 1 kHz frequency sampling using Clampex soft-
ware (v10.6, Molecular Devices) through an acquisition card 
(Digidata 1,550, Molecular Devices), and stored on com-
puter hard disk for further analysis using ClampFit (v10.6, 
Molecular Devices) and/or Origin Lab (Origin Pro 2018).
Islet cells were impaled in the presence of 10 mM glu-
cose in a modified Krebs solution to identify cells exhibit-
ing robust oscillatory electrical behavior typical of β-cells 
(Figure 1a). β-cells were further identified by the character-
istic membrane hyperpolarization and cessation of electrical 
activity upon perfusion without glucose. Data from 89 re-
corded cells were included in the study.
Given the requirement of long-lasting experiments, strict 
criteria for considering a recorded cell as acceptable were ap-
plied: a cell input resistance higher than 100 MΩ, and mem-
brane potential of less than 50 mV, stable for at least 15 min 
before starting the experimental protocols.
2.4 | Statistical analysis
Short-lasting glucose pulses (1-min long, 8 to 12  mM) 
(Figure  1b) produced transient wave-like depolarizations. 
Areas under the wave-like glucose-induced depolarizations 
(AUD) were measured. Specific protocols are detailed in the 
first part of the results section, where the setting of a proce-
dure to analyze sensitivity to glucose is described. Unpaired 
t-tests were performed to compare the AUD differences 
F I G U R E  1  (a) Experimental system. Microdissected islets of Langerhans are attached with micropins to the bottom of the recording 
chamber. The sharp microelectrode accesses the chamber from the top. After cell impalement, the signal is led to the amplifier that subtracts 
the signal coming from the bath (ground). The resulting signal is seen in an oscilloscope and stored in a hard disk. (b) Protocol diagram for 
examining changes in temporal glucose sensitivity. Top illustration. On a basal 8 mM glucose concentration, one-minute long, 12 mM glucose 
pulses are applied; each of them separated from the others by 5 min. Middle illustration. Experimental manipulation. On the basal 8 mM 
glucose concentration, carbachol is applied for 5 min and waiting 5 min to allow washout. Bottom illustration. Same as in the top illustration the 
response of 1-min 8 to 12 mM glucose pulses is obtained to check whether the manipulation as in the middle ilustration has produced a change in 
responsiveness. Note that time scales are not realistic
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statistically before and after the experimental manipulations. 
A critical significance level α of 0.05 was selected before 
data analysis (Table  1). Statistical analysis was done with 
Prism v 7 (GraphPad Software, Inc.).
All the reagents were obtained from Sigma.
3 |  RESULTS
3.1 | Setting up a procedure to test dynamic 
changes in the bioelectric sensitivity of 
pancreatic β-cells to glucose
At glucose concentrations ranging from 7 to 20 mM, oscillatory 
activity of pancreatic β-cells typically consist of hyperpolarized 
(silent) phases and depolarized (active) phases crowned by cal-
cium action potentials both in vitro (Ashcroft & Rorsman, 1989) 
and in vivo (Sanchez-Andres, Gomis, & Valdeolmillos, 1995). 
Increases in the concentration of glucose prolong the active 
phases at the expense of the silent ones (Figure 2a). Transient 
glucose pulses (minutes) result in depolarizing waves that last 
somewhat longer than the pulse duration (Figure  2b). These 
waves are associated with a transient increase in activity (longer 
active phases) that last until the return to membrane potential 
baseline levels. Good quality records (which meet the quality 
criteria specified in Methods) allowed us to consistently record 
stable depolarizing waves for up to two hours (Figure 2b and 2c).
The gold standard to estimate the sensitivity of a given 
system to an agent is to obtain dose–response curves where 
increasing concentrations of the agent lead to corresponding 
responses. These curves can often be fitted nonlinearly, al-
lowing for parameters like the Hill slope, the IC50 and the 
saturation level to be obtained (Figure 3). For the electrical 
response of the pancreatic β-cell, this approach has been suc-
cessfully used, measuring the percentage of time in the ac-
tive phase (%AP) as a function of the glucose concentration 
(Atwater, Carroll, Xu, & Li, 1989; Sanchez-Andres et al., 
1995). Despite the optimality of this procedure to check glu-
cose sensitivity of pancreatic β-cells, it is not useful when 
testing transient changes in sensitivity. Electrophysiological 
records can hardly be stable for more than 1 to 2 hr. Then, 
characterizing changes in glucose sensitivity in this time 
frame is limited because building dose–response curves re-
quires testing different glucose concentrations and waiting 
for stabilization of each of them. Given the slow pace of these 
processes (minutes), a change in sensitivity in this time frame 
(and/or around 1 hr) will contaminate the data. One alterna-
tive is to test the evolution over time of the responses to iden-
tical stimuli assuming the limitations of observing just one 
region in the curve. The challenge is, then, to select the most 
representative region in the dose–response curve. Preliminary 
experiments were performed (data not shown) to check dif-
ferent conditions of the β-cell electrical response to glucose 
concentrations in steps. The findings indicate that jumps from 




























































































Note: The experiments were carried out as described in Methods. Several (3 to 5) control pulses consisting of one-minute long steps to 12 mM glucose from a basal 
concentration of 8 mM glucose were applied. 5 min was the time allowed to pass between pulses. Then, all the experimental conditions described in Results were 
performed, and, later, again, one-minute glucose steps from 8 to 12 mM glucose, separated by 5 min, were applied. These steps produced transient depolarizations in 
which the area was measured (AUD). To obtain control values, the measured areas for every experimental condition were normalized over one and then pooled and 
averaged. Likewise, the AUDs obtained from the experimental conditions were normalized over one, pooled and averaged. The table shows the results obtained for 
5 consecutive glucose pulses applied after removing the TPS-inducing agent. Timing is, thus, 5.5, 11.5, 17.5, 23.5, and 29.5 min because i.e., in the case of the first 
pulse, 5 min were allowed to pass after removing the drug and/or returning to basal 8 mM glucose. Then, this pulse was applied at minute 5 and lasted for 1 min. To 
this end, this pulse is labeled as 5.5 min ending at minute 6. 5 min were allowed to pass before applying the second pulse, at minute 11, and lasting for 1 min. Then, the 
second pulse is labeled as 11.5 min, and so on.
*the p-value is less than 0.05 indicating a statistically significant difference; ns, the p-value is greater than 0.05 indicating a no statistically significant difference.
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8 to 12 mM glucose over 1 min caused a reproducible change 
in the electrical activity (as in Figure 2b and Figure 2c) and 
these are used as controls for sensitivity changes induced by 
experimental agents. This change takes the form of a depo-
larizing wave that can be measured (area under the depolar-
ization, AUD). The rationale for this approach relies on the 
following three assumptions: a. the range 8–12 mM glucose 
falls in the region of the steeper slope on the dose–response 
curve (Figure  3); b. these glucose concentrations make 
physiological sense because they are possible in the normal 
run of the β-cells. Frequently, dose–response curves are built 
from no glucose to 20 or more mM glucose concentrations. 
Indeed, this range allows to complete the curves but far from 
the physiological range as euglycemia is strictly controlled 
and is not usually lower than 6 mM (Sanchez-Andres et al., 
1995) except in hypoglycemic conditions associated with pa-
thology; c. 8 to 12 mM steps imply exposure to relatively high 
glucose concentrations that do not reach (Figure 3) the satu-
ration level. Thus, this step change from 8 to 12 mM glucose 
during a short exposure period can be a useful indicator of 
changes in pancreatic β-cell glucose sensitivity. Furthermore, 
such a short-lasting experimental manipulation can be done 
repeatedly together with the expected duration of stable in-
tracellular impalements. This approach involves applying se-
quentially 8 to 12 mM glucose steps quantifying the effect 
by measuring the AUD, and waiting long enough to allow 
the cell to return to control conditions. We estimated, from 
preliminary experiments, the optimal duration of the steps to 
be 1 min and the time between steps, 5 min, in order to wait 
for the system to return to baseline. A protocol such as that 
described in Figure 1b may be valid, provided the internal 
cell variability is smaller than that expected from sensitivi-
ty-induced changes.
To characterize internal system variability, we applied 3 to 
5 1-min-long pulses, separating one from the other by 5 min 
F I G U R E  2  Pancreatic β-cell responsiveness to steady glucose concentrations and glucose steps. (a) A typical response to sustained glucose 
concentrations. 8 mM glucose causes a pattern of alternating silent (hyperpolarized) and active (depolarized) phases. An increase in 12 mM glucose 
extends the active phases at the expense of the silent ones. (b) Four responses to 1-min steps from 8 to 12 mM glucose concentrations. Striped 
horizontal bars indicate the 1-min glucose increase from 8 to 12 mM. The time of the applied pulse is indicated in parentheses. (c) Reproducibility 
of the responsiveness to glucose steps expressed in terms of the area under depolarization (AUD) over 1 hr. The time scale corresponds to that 
shown in b. Thus, bars at 5, 20, 40, and 60 min are the AUD measured in the pulses as labeled in b. All the traces in the figure were obtained from 
the same β-cell. Note that time scales in a and b are different
F I G U R E  3  Dose–response for glucose, measuring the 
percentage of time in the active phase. 8 and 12 mM glucose 
concentrations are indicated with dotted lines
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to seven cells (n = 36 pulses), and after normalization over 1, 
we obtained a standard deviation average of 0.18; lower 95% 
CI of mean: 0.93; upper 95% CI of mean: 1.05. Changes in 
the measured area which are greater than 20% of controls will 
derive from the experimental treatment, not from the β-cell 
intrinsic variability.
3.2 | Modifiability of the glucose 
responsiveness by carbachol application
1-min long pulses from a glucose concentration of 8 to 
12  mM induced wave-like depolarizations (Figure  4a, 
first row; Figure 4b, first three bars). A quantity of 50 μM 
carbachol applied for 5  min produced a rapid, sustained, 
and rapidly reversible increase in spiking activity to islets 
exposed throughout the experiment to 8.0 mM D-glucose 
(Figure 4a, second row). The test pulses began 5 min after 
removing the carbachol to allow for a complete washing of 
the neurotransmitter, which was confirmed by the return 
of the membrane potential to the baseline. The response to 
these pulses progressively declined toward control levels 
in 40–60 min (Figure 4a, bottom rows, and Figure 4b). The 
cumulative responses from different experiments (n  =  9) 
are shown in Figure  5 and Table  1. This result indicates 
that carbachol induces a lasting increase in the glucose sen-
sitivity of the β-cells (Temporal Potentiation of Sensitivity, 
TPS). TPS tends to return gradually to baseline levels in 
30–60 min.
The specificity of the carbachol action through muscarinic 
receptors was checked by applying carbachol in the presence 
of 10 μM atropine. Figure 6 shows that when the protocol was 
carried out in the presence of atropine, carbachol was unable 
to induce any increase in β-cell responsiveness to glucose 
pulses (n = 10).
3.3 | Glucose requirement for TPS induction
The protocols typically used to induce associative condition-
ing require the temporal convergence of two inputs in a given 
F I G U R E  4  Modifiability of glucose 
responsiveness by carbachol. (a) First row. 
Two representative control traces obtained 
by applying 1-min 12 mM glucose pulses on 
an 8 mM glucose. Second row. A quantity 
of 50 μM carbachol is applied for 5 min 
on 8 mM glucose concentration. Third 
and fourth rows. After carbachol washout, 
1 min, 12 mM glucose pulses were applied 
as in the first row. The time after carbachol 
withdrawal is indicated in parenthesis. (b) 
Areas under the depolarizations (AUD) 
measured before and after carbachol 
application. Bars labeled with asterisks 
correspond to the identically labeled records 
in A (third and fourth rows). All the traces 
in the figure were obtained from the same 
β-cell
F I G U R E  5  Temporal evolution of TPS. Mean and SD of the 
areas under depolarization (AUD) (n = 9) after carbachol application. 
The areas obtained for control pulses were normalized to 1 (broken 
line) to be used as a reference to calculate the normalized values for 
the pulses applied after carbachol. At least three control pulses, usually 
4–5, were applied before carbachol administration
   | 7 of 16SANCHEZ-ANDRES Et Al.
system (Alkon et al., 1992). The protocol used for TPS induc-
tion involved the simultaneous and transitory effects of two 
secretagogues: glucose and carbachol. The question arises as 
to whether TPS results only from carbachol action or if it 
requires the joint action of both inputs. The answer to this 
question was obtained by removing the glucose from the per-
ifusion solution before applying carbachol (Figure 7a). After 
removing carbachol, basal glucose (8mM) was restored, and 
glucose pulses (12 mM) were applied to compare with the 
responses obtained before carbachol application (Figure 7a, 
top row versus bottom row). Carbachol applied in the ab-
sence of glucose was unable to produce TPS (Figure 7a and 
Figure 7b) (n = 10). Consequently, TPS induction requires 
the presence of carbachol and glucose simultaneously.
F I G U R E  6  Atropine prevents TPS 
establishment. (a) Wavelike-induced 
depolarizations by 8 to 12 mM glucose 
steps before (top row) and after (bottom 
row) carbachol treatment in the presence of 
atropine (10 μM). (b) Analysis of the areas 
under depolarization (AUD) when carbachol 
was applied together with atropine (see 
text for details on timing for atropine 
application). Bars labeled with asterisks 
correspond to the similarly labeled records 
in (a), bottom row. All the traces in the 
figure were obtained from the same β-cell
F I G U R E  7  Effect of carbachol 
application in the absence of glucose. (a) 
Top row. Two representative traces of 
1-min long, 12 mM glucose pulses applied 
on 8 mM glucose. Middle row. Glucose 
is removed from the perfusing solution 
(see also Figure 3) and, then, 50 μM 
carbachol is applied for 5 min. Note the 
absence of carbachol effect. Bottom row. 
After carbachol washout, 8 mM glucose 
concentration is added to the perifusion 
solution, and 1-min long, 12 mM glucose 
pulses were applied as in the top row. (b) 
Comparison between the areas under the 
depolarizations (AUD) induced by glucose 
pulses before and after carbachol treatment 
in the absence of glucose. All the traces 
in the figure were obtained from the same 
β-cell
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3.4 | TPS induction by other nutrient 
secretagogues
When carbachol was applied in the absence of glucose, but 
in the presence of either 10 mM glyceraldehyde (Figure 8) 
(n  =  4) or 10  mM 2-ketoisocaproate (Figure  9) (n  =  8), a 
subsequent intensification of the bioelectrical response to a 
rise in D-glucose concentration was observed. The cumula-
tive responses for both secretagogues are shown in Table 1. 
The substitution of 8.0 mM D-glucose for 10 mM l-leucine 
at the time of carbachol administration did not intensify 
the bioelectrical response to the rise in glucose concentra-
tion from 8.0 to 12.0 mM consistently. The experiment was 
replicated in four cells, and the potentiation was observed 
only consistently in two of them (Figure 10). Table 1 pro-
vides the values for the test pulses under the leucine effect 
when TPS was induced. These data highlight a tendency that 
was not confirmed (see Discussion). In the other two cells, 
the potentiation could not be observed (data not shown; see 
Discussion). Exposing the islets to palmitate (625 μM) dur-
ing carbachol administration did not produce any significant 
increase in response to test pulses (n = 6; data not shown).
F I G U R E  8  Effect of glyceraldehyde 
(Gly). (a) Control representative 
depolarizations induced by 1-min long steps 
from 8 to 12 mM glucose. After control 
pulses, glucose is replaced by 10 mM 
glyceraldehyde before administering 50 μM 
carbachol, which is maintained for 5 min. 
(b) Steps as in (a) after 5 min of replenishing 
the 8 mM glucose and removing the 
glyceraldehyde. (c) AUD measurements 
throughout the experiment. All traces in the 
figure were obtained from the same β-cell
F I G U R E  9  Effect of ketoisocaproate 
(KIC). (a) Representative control 
depolarizations induced by 1-min long steps 
from 8 to 12 mM glucose. After control 
pulses, glucose is replaced by 10 mM KIC 
before administering 50 μM carbachol, 
which is maintained for 5 min. (b) Steps as 
in (a) after 5 min of replenishing the 8 mM 
glucose and removing the KIC. (c) AUD 
measurements throughout the experiment. 
All traces in the figure were obtained from 
the same β cell
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3.5 | TPS induction dependence on 
membrane potential
The best-known case of cellular associative condition-
ing is probably long-term potentiation (LTP) (Bliss & 
Collingridge, 1993; Bliss & Lomo, 1973), extensively stud-
ied in neural systems. The LTP induction implies that two 
stimulus act at the same time on one cell. It is known that 
the role of one of the two associated inputs provides an ap-
propriate level of depolarization while the other acts. This 
role has been experimentally tested, replacing one of the 
inputs by a depolarization, induced either pharmacologi-
cally or through depolarizing current injection. The latter 
technique is difficult when studying the pancreatic β-cell 
because the sharp electrodes used for impalements cannot 
reliably drive the membrane potential towards a steady de-
polarized level. However, diazoxide and tolbutamide are 
known to change the membrane potential by acting on 
K-ATP channels. The K-ATP channels are the decisive 
step in glucose metabolism. Without glucose this channel 
stays open, and the cells hyperpolarize. Conversely, glu-
cose metabolism increases the ATP/ADP ratio closing the 
channels and inducing cell depolarization and insulin re-
lease (Wu, Ding, Wang, & Chen, 2020). Diazoxide keeps 
the channels open even in the presence of glucose, forcing 
the cells to stay hyperpolarized. Tolbutamide works in the 
opposite way, closing the channels and depolarizing the 
cells even without glucose. Consequently, the use of these 
drugs acting distally on the membrane may be critical to 
test the need for intermediate stages of glucose metabo-
lism in the induction of TPS. To verify the effect of main-
taining the membrane hyperpolarized during carbachol 
administration, the following protocol was used: Several 
(3 to 5) control glucose pulses were applied before add-
ing 20 μM diazoxide to the superfusion solution (including 
8 mM glucose) and waiting 3 to 5 min until the diazoxide-
induced hyperpolarization was established. Then, 50  μM 
carbachol was applied for 5  min. Both carbachol and di-
azoxide were removed from the superfusion solution. 
Recovery of diazoxide hyperpolarization was usually done 
in the range of 5–7 min. Then, 8 to 12 mM glucose steps 
were applied and compared with controls. The absence of 
TPS due to diazoxide suggests (Figure 11) that depolari-
zation of the plasma membrane was necessary for TPS to 
occur (n = 5).
A mirror image of that recorded in the β-cells exposed to di-
azoxide was observed when the cholinergic agent was admin-
istered to β-cells exposed to 50 μM tolbutamide (Figure 12) 
(n = 4) without glucose. Thus, in these cases, a later potenti-
ation of glucose-induced bioelectrical activity was seen. The 
cumulative responses in the presence of diazoxide and tolbut-
amide are shown in Table 1. The potentiation in the glucose 
response after tolbutamide and carbachol removal indicates 
that the critical requirement to be associated to the cholinergic 
agonist is the depolarization or its intracellular consequences, 
rather than the mechanisms secondary to glucose metabolism. 
TPS induced in the presence of tolbutamide exhibits similar 
properties to that induced by glucose, with maximal values 
obtained for the first stimulus after carbachol withdrawal and 
a progressive decline toward the baseline over a 30–60-min 
period.
The temporal potentiation of β-cell sensitivity to glucose may 
be a Ca2+-sensitive process modifying the Ca2+-dependence 
of the β-cell electrical activity (Ribalet & Beigelman, 1981; 
F I G U R E  1 0  Effect of leucine. 
Leucine does not consistently produce 
TPS. The figure shows a representative 
case where TPS is induced. (a) 1-min 
glucose control steps 8 to 12 mM. After 
the control pulses, glucose is replaced by 
10 mM leucine before administering 50 μM 
carbachol, which is maintained for 5 min. 
(b) Steps as in A after 5 min of replenishing 
the 8 mM glucose and removing the leucine. 
(c) AUD measurements throughout the 
experiment. Bars labeled with asterisks 
correspond to the identically labeled records 
in (b). All traces in the figure were obtained 
from the same β-cell
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Sanchez-Andres et al., 1988). Indeed, it was not observed when 
Ca2+ entry during carbachol application was blocked by 5 mM 
Co2+ (n = 4; data not shown). This requirement seems to be 
precisely on the extracellular calcium entry as 1 μM caffeine, 
capable of increasing the intracellular Ca2+ concentrations by 
releasing the cation from intracellular stores, could not produce 
TPS (n = 5; data not shown).
3.6 | Blocking TPS induction by 
staurosporine
TPS implies a sustained effect that lasts beyond the appli-
cation of carbachol. This finding suggests the participa-
tion of some intracellular molecules capable of remaining 
activated after carbachol withdrawal. Several kinases are 
F I G U R E  1 2  Effect of tolbutamide. Effect of carbachol application in the absence of glucose, but in the presence of 50 μM tolbutamide. (a) 
Top row. 1-min glucose control steps 8 to 12 mM. After control pulses, glucose is replaced by 50 μM tolbutamide. When the depolarizing effect 
of tolbutamide is established, 50 μM carbachol is added for 5 min. Then, tolbutamide is removed, and an 8 mM glucose concentration is added to 
the perifusion solution. Bottom row. Steps as in the top row, after 5 min of replenishing the 8 mM glucose and removing the tolbutamide. (b) AUD 
measurements throughout the experiment. Bars labeled with asterisks correspond to the similarly labeled records in A, bottom row. All the traces in 
the figure were obtained from the same β-cell
F I G U R E  1 1  Effect of diazoxide. (a) 
1-min long glucose steps 8 to 12 mM before 
(top row) and after (bottom row) carbachol 
treatment in the presence of diazoxide 
(20 μM). (b) Analysis of the areas under the 
wavelike-induced depolarizations (AUD) 
when carbachol was applied in the presence 
of diazoxide. Bars labeled with asterisks 
correspond to the similarly labeled records 
in (b). All the traces in the figure were 
obtained from the same β-cell
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thought to be responsible for this type of sustained re-
sponses (Rasmussen et al., 1995; Wang & Feng, 1992). 
To verify the participation of kinases in the induction 
of TPS, we performed experiments with 30  nM stauro-
sporine. Under these conditions, TPS was not induced 
(Figure 13) (n = 3). This result suggests that kinases are 
involved in TPS induction. One of them, the PKC, has 
been shown to produce sustained effects. To test this 
possibility, we conducted experiments (n = 7) using the 
phorbol ester 2  μM PMA. Regardless of the incubation 
time (up to 1 hr), the induction of TPS was not seen.
3.7 | De novo protein synthesis is not 
required for TPS induction
It is generally accepted that long-term changes in synaptic 
transmission require activation of de novo protein synthesis 
while short-term changes do not. TPS duration indicates that 
it is a short-term change. The execution of the experiments in 
the presence of the protein synthesis blocker cycloheximide 
allows for this possibility to be tested. The islets were prein-
cubated in 50 μM cycloheximide for two hours before running 
the protocols, and the drug was kept in the perifusion medium 
throughout the experiment (n = 3). Cycloheximide was not 
able to prevent TPS induction (Figure 14), suggesting its in-
dependence from de novo protein synthesis. Table 1 provides 
the cumulative responses in the presence of cycloheximide.
4 |  DISCUSSION
The parasympathetic effect on the endocrine pancreas has 
been well characterized. Acetylcholine and its analogs are 
known to increase insulin release both in vitro and in vivo 
(Kajinuma, Kaneto, Kuzuya, & Nakao, 1968; Malaisse 
et al., 1967; Sharp, Culbert, Cook, Jennings, & Burr, 1974). 
Stimulation of the parasympathetic vagus nerve leads to 
an increase in insulin secretion (Bergman & Miller, 1973; 
Frohman, Ezdinli, & Javid, 1967; Kaneto, Kosaka, & Nakao, 
1967; Porte et al., 1973) blockable by atropine. This increase 
is mediated through muscarinic receptors (Gilon, Nenquin, & 
Henquin, 1995; Malaisse, 1986).
The preabsortive or cephalic phase of insulin secretion is 
mediated by the muscarinic action of acetylcholine released 
by the vagus nerve (Rasmussen, Zawalich, Ganesan, Calle, 
& Zawalich, 1990). It can be assumed that this effect hap-
pens in the presence of a basal glucose concentration (around 
6–8 mM) since it takes place before hyperglycemia is induced 
by nutrient absorption. We have mimicked vagal activation by 
applying the cholinergic agonist carbachol for 5 min together 
with 8 mM glucose and compared the 8 to 12 mM glucose-in-
duced depolarizing waves before and after carbachol treat-
ment. The depolarizing waves were larger after the treatment 
and returned gradually to control levels after 30–-60  min. 
This increase in the size of the depolarizing waves implies 
increased responsiveness of the system, as the stimuli were 
identical before and after carbachol treatment. The potentia-
tion in glucose response is muscarinic because it is blocked 
with atropine. Applying carbachol without glucose did not 
change β-cell responsiveness to glucose. All these data taken 
together show that the cell's response to glucose is not fixed 
but is temporally modified by the combined effect of glucose 
and carbachol, and neither can produce the effect when ap-
plied separately. The modification takes the form of a tempo-
rary potentiation of sensitivity (TPS) for less than one hour.
This temporary change in sensitivity can be interpreted as a 
short-term memory mechanism. Such a temporary potentiation 
F I G U R E  1 3  Effect of staurosporine. 
(a) 1-min glucose steps of 8 to 12 mM 
before (upper row) and after (lower row) 
carbachol treatment in the presence of 
30 nM staurosporine throughout the 
experiment. (b) AUD measurements 
throughout the experiment. The bars labeled 
with asterisks correspond to the records 
labeled in the same way in A, bottom row. 
All traces in the figure were obtained from 
the same β-cell
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of sensitivity is compatible with the view that a vagal dis-
charge occurring in the cephalic phase of digestion, when 
a meal is predicted to occur, causes β-cells to increase their 
glucose response and optimize their responsiveness. In other 
words, the gain (sensitivity) in the system will be maximized 
at meals and will be minimal between meals. This mechanism 
will share neural properties with classical Pavlovian learning 
and can explain the early Planelles and Luwisch (1935, 1936) 
description that was later widely characterized by Woods as 
conditioned hypoglycemia (Woods, 1983, 2013).
The potentiation of glucose sensitivity induced by car-
bachol may also occur in the case of other secretagogues. 
Glucose induces insulin secretion by activating the so-called 
canonical or initiating pathway (Henquin, 2000) for insulin 
secretion which blocks K-ATP channels causing cell depolar-
ization. The potentiation could be expected to be reproduced 
in cases where the pathways involved are similarly affected. 
Insulin secretion is stimulated by nutrients such as glucose, 
amino acids, and free fatty acids, as well as incretin hormones 
to adapt glucose homeostasis in response to a meal. While a 
thorough exploration of the possibilities is beyond the scope 
of this paper, we have tested several representative substrates. 
Glyceraldehyde, a lateral end-product of glycolysis, mimics 
the effect of glucose on insulin secretion (Taniguchi, Okinaka, 
Tanigawa, & Miwa, 2000). Glyceraldehyde allows TPS in-
duction by carbachol indicating that TPS does not require the 
steps associated with glycolysis to occur. α-Ketoisocaproic 
acid (KIC) is a metabolite of leucine that induces insulin se-
cretion from β-cells (Panten, Kriegstein, Poser, Schönborn, & 
Hasselblatt, 1972). KIC directly inhibits the K-ATP channels 
in pancreatic β-cells, while it is still unclear whether direct in-
hibition of the K-ATP channels by KIC contributes to insulin 
release (Heissig, Urban, Hastedt, Zünkler, & Panten, 2005). 
In our experiment, KIC allowed TPS induction while its pre-
cursor leucine did not do so consistently, failing in half of 
the cases. This ratio is reasonably adjusted to that described 
for leucine-induced insulin secretion in single β-cells (39.2%) 
(Hiriart, Sanchez-Soto, Ramirez-Medeles, & Malaisse, 
1995). This indicates the existence of two β-cell subpopu-
lations based on their ability to respond to leucine. Research 
shows that one mechanism by which leucine induces insu-
lin secretion is through its conversion to KIC (Newsholme, 
Brennan, & Bender, 2006). However, leucine and KIC also 
stimulate insulin release through different mechanisms (Gao 
et al., 2003). Recently, it has been reported that leucine reg-
ulates insulin secretion by modulating adrenergic α2 recep-
tors through the mTOR pathway (Yang et al., 2012). This 
finding highlights the system's ability to direct the balance 
between leucine-KIC toward different targets. This balance 
seems to be of high physiological relevance insofar as the 
effects of KIC are in the short-term range (K-ATP inhibition), 
while those of leucine imply that mTOR affects long-term 
processes such cell growth and proliferation. For this study, 
it is worth noting that the KIC-leucine data point to the in-
volvement of the distal components of the canonical insu-
lin secretion pathway centered on the consequences of the 
K-ATP channel modulation. It is also worth noting that pre-
vious considerations about the role of the leucine-KIC pair 
have supported the hypothesis based on a functionally regu-
lated balance between KIC transamination to leucine and its 
catabolism to increase cytosolic Ca2+ and insulin secretion 
(Gao et al., 2003). Our results appear to be more consistent 
with the hypothesis of functional heterogeneity of pancreatic 
β-cells in their response to leucine (Hiriart et al., 1995).
F I G U R E  1 4  Effect of cycloheximide. 
(a) A quantity of 50 μM cycloheximide 
was added to the perfusion solution 2 hr 
before starting the protocol and maintained 
throughout the experiment. Top row. 1-min 
glucose control steps 8 to 12 mM. Bottom 
row. After carbachol removal, glucose 
pulses as in the top row were applied. 
(b) AUD measurements throughout the 
experiment. The bars labeled with asterisks 
correspond to the records labeled in the 
same way in (a), bottom row. All the traces 
in the figure were obtained from the same 
β-cell
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Moreover, we tested the effect of palmitate, a fatty acid that 
exhibits a particular behavior: the insulin secretion induced 
by palmitate depends on glucose concentration (Carpinelli, 
Picinato, Stevanato, Oliveira, & Curi, 2002). At low glucose 
concentrations (5.6 mM), palmitate reduces insulin secretion 
while promoting it at high levels (16.7 mM). The reason for 
this effect is that at low glucose concentrations, palmitate di-
verts glycerol-phosphate into lipid synthesis, which reduces 
glucose from the glycolytic flux, and then reduces glucose 
oxidation and ATP production. At high glucose concen-
trations, the glycolytic flux is sufficient to provide glycer-
ol-phosphate for lipid synthesis and carbons for the Krebs 
cycle. The experiments with palmitate were performed at low 
glucose concentrations (8 mM), then, as expected, with pal-
mitate, TPS did not occur.
Two well-known pharmacological tools have been used to 
evaluate the distal step of glucose metabolization: diazoxide 
and tolbutamide. When carbachol was applied together with 
glucose and diazoxide, TPS was not induced. Since diazoxide 
does not prevent glucose intake or metabolization (Aizawa 
et al., 1994; Gembal, Gilon, & Henquin, 1992; Kharade 
et al., 2019), these data reveal the need for the requirement of 
membrane depolarization and calcium entry to induce TPS. 
Tolbutamide, an antidiabetic drug, acts in a manner opposite 
to diazoxide, blocking ATP-K channels, depolarizing cells, 
and inducing the opening of calcium channels and insulin se-
cretion even in the absence of glucose. Carbachol, in the pres-
ence of tolbutamide, did not require glucose to induce TPS, 
which supports the role of glucose to increase the intracellu-
lar calcium concentration; the other intermediate metabolic 
steps are unnecessary for this purpose.
It has been shown that kinases are critical for β-cells 
to function and participate in cholinergic pathways to reg-
ulate insulin secretion (Persaud, Jones, & Howell, 1991) 
and generate sustained cellular responses in the islets 
of Langerhans (Alkon & Rasmussen, 1988; Rasmussen 
et al., 1995). The execution of the basic protocol (glucose 
and carbachol) in the presence of the nonspecific inhib-
itor of kinases staurosporine shows that the induction of 
TPS is prevented, suggesting the participation of kinases. 
Specifically, the action of PKC in pancreatic β-cells is 
complex, inhibits phase 1 and stimulates phase 2 of insulin 
secretion induced by both glucose and carbachol (Thams, 
Capito, Hedeskov, & Kofod, 1990). To test the possible 
role of this kinase, we conducted experiments in the pres-
ence of the activator of PKC PMA. PMA was not able to 
induce potentiation. This suggests that staurosporine may 
inhibit other targets that play a role in this TPS process. 
More research should be conducted to clarify the role of 
PKC and other kinases in the induction of TPS.
The data presented also highlight distal mechanisms as 
candidates responsible for TPS induction. However, we can-
not specify which one is responsible for the effect. In any 
event, it is interesting to observe the result of pooling the 
means of the AUDs of the different conditions where we 
have found TPS (basic carbachol protocol, glyceraldehyde, 
KIC, leucine, tolbutamide, cycloheximide) (cells, n = 32). As 
shown in Figure 15, one phase decay nonlinear fitting pro-
vides R squared goodness of fit of 0.98, which allows us to 
suggest that a single mechanism underlies at least the deacti-
vation of TPS.
4.1 | TPS as a case of cellular associative 
conditioning
One question arises from the data presented: can TPS be con-
sidered as associative cellular conditioning? Until now, the 
concept of memory has been restricted to neural systems and 
immunity. The TPS in β-cells is limited under a behavioral 
scope, but meets the requirements to be considered Hebbian 
(Nicoll, Malenka, & Kauer, 1990), and shows parallels with 
other mechanisms of cellular memory, such as the induc-
tion of long-term potentiation and associative learning in 
the Β-photoreceptor of  Hermissenda crassicornis (Alkon 
et al., 1992) or the abdominal ganglia of  Aplysia califor-
nica (Kandel & Schwartz, 1982). In all these cases, properly 
paired stimuli can modify the response capacity of the system 
to one of them. Further, one of the inputs can be replaced 
by the calcium load induced by depolarization, and poten-
tiation is impaired by membrane hyperpolarization even in 
the presence of properly paired stimulation. Our finding re-
veals a possible generalization of mechanisms of associative 
conditioning to non-neural systems. In this case, the dura-
tion (up to one hour) and the lack of cycloheximide action, 
which indicates the absence of de novo proteins for the TPS 
F I G U R E  1 5  Fit to a single exponential decay of the AUD 
pooled means from the cases in which TPS was induced (basic 
carbachol protocol, glyceraldehyde, KIC, leucine, tolbutamide, 
cycloheximide; n = 32). Data show mean, SD. R squared goodness of 
fit of 0.98
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induction, suggest that it is a short-term process (Burgoyne, 
1989; Schwartz & Greenberg, 1987).
4.2 | Physiological implications
Although the main effect of muscarinic agents is to en-
hance glucose-induced insulin secretion (Sanchez-Andres 
et al., 1988), it seems that the integrated action of the para-
sympathetic system is much more complicated (Woods & 
Porte, 1978). Several observations support this possibility: 
(a) a given amount of glucose is more effective in stimu-
lating secretion when given orally than when administered 
intravenously (Louis Sylvestre, 1976), which points to the 
involvement of neural mechanisms superimposed on the hu-
moral; (b) atropine can inhibit the insulin response to ingested 
glucose, while not affecting the secretory response to infused 
glucose (Henderson, Jefferys, Jones, & Stanley, 1976); (c) 
vagotomy suppresses the development of diet-induced obe-
sity (Sclafani, Aravich, & Landman, 1981). The best known 
parasympathetically mediated physiological event is prob-
ably the reflex stimulation of insulin secretion (also called 
preabsortive or cephalic) that occurs before food enters the 
gut like a reflex salivary secretion. Classically, this increase 
in insulin secretion has been interpreted as being preparatory 
for the impending absorption of nutrients. To the extent that 
the experimental conditions for inducing TPS replicate those 
of the cephalic phase of insulin secretion (vagal discharge on 
basal glycemia), the physiological interpretation of this phase 
may be reconsidered. The cephalic phase of insulin secre-
tion would play the classically assumed preparatory role, but 
it would also be responsible for establishing the sensitivity 
(gain) of the system to glucose. This gain would be at its 
highest point together with meals, returning the gain to base-
line levels between meals when the physiological require-
ment must be in the opposite direction: maintaining a lower 
sensitivity, secreting insulin minimally, since the direction of 
the energy flux must be from the stores to the blood. This 
possibility adds complexity and enriches the physiological 
capabilities of cholinergic action, which has recently ex-
panded with the observation that muscarinic agonist pulse 
trains and synchronizes the islets of Langerhans. As stated 
in other studies (Adablah, Vinson, Roper, & Bertram, 2019), 
this would result in coordinated insulin secretion of the islet 
population. Our data highlight a lasting coordination after a 
muscarinic pulse (or vagal discharge).
Furthermore, at the level of cellular physiology, our data 
suggest that the pancreatic β-cell can integrate a neural sig-
nal to sustainably modify its responsiveness. This integration 
would endow these cells with the properties of coincidence 
detection (when the two inputs act in proper correlation), 
and prediction capability (the cells were ready for glucose 
challenges before glucose increased in the blood). The results 
of this research point to a generalization of the concept of 
associative conditioning being exhibited even in non-neural 
tissues, which show particularities depending on the physio-
logical demands to be subserved. In the case of β-cell TPS, 
a short-term memory process, increases the gain (sensitivity) 
of the system during meals, keeping it low between meals, 
and adapting the system to the cyclic nature of food intake.
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